Contents
Current Pharmaceutical Design, Volume 16 - Number 11
Bisphosphonates as Treatment of Bone Metastases
, 16(11): 1262 - 1271Ingunn Holen and Robert E. Coleman
DOI: 10.2174/138161210791034003
Targeting RANK/RANKL in the Treatment of Solid Tumours and Myeloma
, 16(11): 1272 - 1283C.H. Buckle, H.L. Neville-Webbe, P.I. Croucher and M.A. Lawson
DOI: 10.2174/138161210791034021
The CXCR4/SDF-1 Chemokine Axis: A Potential Therapeutic Target for Bone Metastases?
, 16(11): 1284 - 1290A.C. Hirbe, E.A. Morgan and K.N. Weilbaecher
DOI: 10.2174/138161210791034012
Bone Morphogenetic Proteins and its Receptors; Therapeutic Targets in Cancer Progression and Bone Metastasis?
, 16(11): 1291 - 1300Jeroen T. Buijs, Maj Petersen, Geertje van der Horst and Gabri van der Pluijm
DOI: 10.2174/138161210791033987
TGF-β Pathway as a Therapeutic Target in Bone Metastases
, 16(11): 1301 - 1312Patricia Juarez and Theresa A. Guise
DOI: 10.2174/138161210791034049
Identification of Molecular Targets Associated with Ethanol Toxicity and Implications in Drug Development
, 16(11): 1313 - 1355Lin-Lin Wang, An-Kui Yang, Shu-Ming He, Jun Liang, Zhi-Wei Zhou, Yong Li and Shu-Feng Zhou
DOI: 10.2174/138161210791034030
Webmaster Contact: info@benthamscience.net